Gyre Therapeutics (GYRE) Non-Current Deferred Revenue (2009 - 2026)
Gyre Therapeutics' Non-Current Deffered Revenue was $829,000 in Q2 2026, down 6.2% from $884,000 a year earlier and down 1.3% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Non-Current Deferred Revenue (2009 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Deffered Revenue at Gyre Therapeutics came in at $852,000, down 8.2% from FY2024.
- Non-Current Deffered Revenue shows a three-year compound annual growth rate of 93.3% (FY2022 to FY2025).
- In earlier years, Non-Current Deffered Revenue was $928,000 in FY2024 (+335.7%), $213,000 in FY2023 (+80.5%) and $118,000 in FY2022.
- The Q2 2026 figure marks the lowest quarterly Non-Current Deffered Revenue since Q3 2024.
- Compared with a year earlier, Non-Current Deffered Revenue has declined for three straight quarters, with growth averaging 198.3% over the last seven quarters.
- The best year-over-year quarter for Non-Current Deffered Revenue over five years was Q3 2025 (growth of 368.1%); the worst was Q4 2025 (a decline of 8.2%).
- Per Business Quant data, GYRE's Non-Current Deffered Revenue in the three quarters before Q2 2026 was $840,000 (Q1 2026), $852,000 (Q4 2025) and $866,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Gyre Therapeutics | 487.81 Mn | 295.13 Mn | 30.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.56 Mn |
| Jun 30, 2026 | 829,000.00 |
| Mar 31, 2026 | 840,000.00 |
| Dec 31, 2025 | 852,000.00 |
| Sep 30, 2025 | 866,000.00 |
| Jun 30, 2025 | 884,000.00 |
| Mar 31, 2025 | 905,000.00 |
| Dec 31, 2024 | 928,000.00 |
| Sep 30, 2024 | 185,000.00 |
| Jun 30, 2024 | 192,000.00 |
| Mar 31, 2024 | 203,000.00 |
| Dec 31, 2023 | 213,000.00 |
| Dec 31, 2022 | 118,000.00 |
| Dec 31, 2016 | 47,000.00 |
| Jun 30, 2016 | 73,000.00 |
| Mar 31, 2016 | 183,000.00 |
| Dec 31, 2015 | 292,000.00 |
| Sep 30, 2015 | 401,000.00 |
| Dec 31, 2014 | 729,000.00 |
| Dec 31, 2012 | 1.18 Mn |
API Access
Gyre Therapeutics Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();